Sign in

CIK 0001339970 · Non-accelerated filer<br>Smaller reporting company

aTYR PHARMA INC

Sign in to watch
Ticker
ATYR
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
203435077
Phone
8587318389
Business address
10240 SORRENTO VALLEY ROAD, SUITE 300, SAN DIEGO, CA, 92121
  1. CORRESP Other Correspondence Between Filers and SEC Staff
  2. S-3/A Offering Registration Statement
  3. SC 13G/A Stake Amended Statement of Ownership
  4. UPLOAD Other SEC-generated Letter
  5. S-3 Offering Registration Statement
  6. 8-K Event Material agreement
  7. 424B5 Offering Prospectus
  8. 4 Open-market sale General Counsel sold 4,651 shares at $0.45 ($2,093)
  9. 8-K Event Regulation FD disclosure
  10. S-8 Other Securities Offered to Employees in Benefit Plans
  11. 10-Q Report Quarterly Report
  12. 8-K Event Results of operations
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 8-K Event Executive or director change · Shareholder vote results
  20. SC 13G Stake Amended Statement of Ownership

Page 20 of 38 · 755 filings